Navigation Links
Equateq Delivers Pharma-Grade DGLA for Skin Health
Date:1/27/2009

Scotland-based company to showcase synthetic DGLA at InformEx

Pharma-grade DGLA used to treat eczema, psoriasis, arthritis

SAN FRANCISCO, Jan. 27 /PRNewswire/ -- The omega-6 fatty acid DGLA, which has potent anti-inflammatory actions and has not previously been readily accessible from any natural source, is now available in commercial quantities and to a super-pure specification, specialist lipid manufacturer Equateq announced in advance of InformEx 2009.

Equateq announced that it has successfully synthesized omega-6 DGLA (Dihomma-Gamma-Linolenic Acid) up to 98% purity. The company now markets the fatty acid as EQT-101, available to researchers, pharmaceutical and cosmetic companies from gram to kilogram batch sizes. Synthetic DGLA, the first public outcome of Equateq's lipid synthesis programme, which the company has been pursuing at its purpose-built facility in the Western Isles of Scotland, will be presented at InformEx 2009 in San Francisco.

As a precursor to important eicosanoids, hormone-like substances that regulate cell function and have important anti-inflammatory functions, DGLA (20:3 n-6) performs as a 'sister' fatty acid to omega-3 EPA. Thus DGLA has potential to treat conditions such as eczema, psoriasis, asthma and arthritis. Found only in some organ meats and glands, and human breast milk, DGLA has been difficult to source in nature. Previously, researchers relied on sourcing GLA from evening primrose or borage oils, which can convert into DGLA in the body. Now, with the introduction of a synthesized brand, researchers can experiment with direct inputs of DGLA.

"There is a lot of wizardry involved in this, as my team has essentially mimicked processes from within the human body in order to deliver DGLA in a super-pure form," said Equateq CEO Adam Kelliher. "It is a magnificent first result, and we expect to be announcing characterization of several other lipid APIs in the months and years to come."

Synthetic DGLA has the best potential as the active ingredient within a topical cream for treatment of eczema, psoriasis and atopic dermatitis. Research indicates that DGLA's benefits for hyper-proliferative skin disorders may be due to the fatty acid's role as the raw material in the creation of potent anti-inflammatory compounds called prostaglandin E1 and 15-HETrE. In other recent research showing that DGLA countered the role of inflammatory prostaglandin E2 in animal models, the authors concluded that DGLA administration in humans could be more effective than GLA in reducing symptoms of atopic eczema.

"Cosmetics and pharmaceutical companies, or anyone in the business of smooth healthy skin, will grasp the potential of DGLA," Kelliher said. "It can be the basis of a breakthrough treatment having none of the side effects of steroids, and we can now deliver it to interested parties in a GMP-certified form."

Equateq will present EQT-101 at the InformEx show in San Francisco, January 27-30, at the Scottish Development International stand number 1142 and during an exhibitor showcase on January 27. Equateq's cGMP facility in Scotland has been operating for more than 20 years as a dedicated lipid development plant. The privately-owned company sells crystallised omega oil concentrates to the food and nutraceutical sectors and its super-pure Ultra-Rx range of compounds are used by researchers and pharmaceutical companies for exploring Investigational New Drugs.

For further information or interviews with representatives from Equateq, please contact Dr. Adrian Hughes at +31 646124483.


'/>"/>
SOURCE Equateq
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Senate Finance Committee Delivers Childrens Insurance
2. U.S. House Gets the Job Done for Americas Working Families and Delivers Childrens Insurance
3. Sheffield Teaching Hospitals NHS Foundation Trust delivers same day patient discharge via BigHand Digital Dictation
4. Nothing But Nets Delivers 740,000 Bed Nets to Central African Republic
5. Vivisimo Search Delivers Medical Knowledge to Global Health-Care Community
6. InVitria's Cellastim Delivers Superior Results in CHO Cell Culture
7. New Internet Service Delivers Relief to Families of Those in Long-Term Care
8. New Software Streamlines Interface Management, Delivers More System Security and Greater IT Control
9. Healthplace America Delivers the First and Only Surgery Benefit Management Solution Through the Healthplace Benefit(TM)
10. Analog Devices Healthcare Director Delivers Speech on Role of Analog Semiconductors in Next-Generation Portable Medical Equipment : ADI's Pat O'Doherty is a featured speaker at electronica 2008.
11. Decision Intelligence Delivers Marketing Contact Optimization Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... Boca Raton, FL (PRWEB) , ... January 20, 2017 , ... ... highest level of nutritional and bodybuilding supplements, announced it attended the January ECRM trade ... a respected bodybuilder and nutritional scientist who was determined to create a line of ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Mary Magdalene: Grace is Greater than ... the woman who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace is Greater than Sin” ... career as an educator interacting with countless women who had little knowledge of the ...
(Date:1/20/2017)... ... 2017 , ... D R Burton Healthcare Products LLC, makers ... in a study indicating superior performance against competitive products in secretion clearance. ... Positive Expiratory Pressure Devices During Simulated Breathing“ was published in the winter issue ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Land of More and More”: a ... world hunger, and shares the simple and achievable answer. “The Land of More and ... the Fairview Missionary Church in Angola, Indiana where he works with the children’s ministry ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... Next week ... will be repealed by Congressional political games that circumvent health needs of over 30 ... Rally” capture the human anxieties and needs government public servants were suppose to prioritize. ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017 This report on ... and future scenario of the global market. Large number ... consumption. Severe chronic constipation is a major side effect ... laxatives. Hence, novel targeted therapy has been prescribed to ... launch of targeted medicines, and growing awareness about the ...
(Date:1/19/2017)... NEW YORK , January 19, 2017 ... global market for cryotherapy is set to witness a CAGR of ... North America will continue to be the leading ... ... Suppliers are emphasizing on ensuring affordable and adequate supply ...
(Date:1/19/2017)... Fla. , Jan. 19, 2017  Sensus ... medical device company specializing in the treatment of ... as keloids, with superficial radiation therapy, today announced ... full year 2016 financial results on Thursday, February 2, ... Company will hold a conference call with the ...
Breaking Medicine Technology: